ScripsAmerica Inc. (SCRCQ)

[coolerheadsprevail]

imo, some of these guys aren't going anywhere. once they realized how clueless bss was at running a pubco, they dug right in. i believe ab actually set up a new company for a sales team because he saw the excessive commissions bss was paying out. until bss is replaced by a ceo with an education and experience in pharma, you will always have these people around.

I concur with your conclusion.

However, re: Adam Brosius, it is noteworthy that prior to his quick formation of his new sales/marketing/business development company, SCRC's selling expenses were an acceptable "non-eyebrow-raising" 45%. The timing of his coming on board aligns with the jump in SCRC's selling expenses from 45% in Q1'14 and Q'2'14 to 65% in Q3'14... ...so, although only insiders know exactly what contributed to this near 50% jump in selling expenses, the information available in the public space thus far seems to make a fairly strong argument that it involved Adam Brosius coming on board in a middleman capacity in some way.

So, in essence, Adam Brosius did NOT jump on board BECAUSE he saw that SCRC was over-paying commissions; rather, SCRC's commissions were acceptable prior to Adam Brosius' involvement, and that SCRC's commissions became excessive at around the same time that Adam Brosius just so happened to come on board (i.e. Adam Brosius IS the reason that selling expenses shot up approx 50% from 45% to 65%). Coincidence?

As of now, seeing as no new hospital/physician networks have been signed up (because approved orders have not increased since Brosius came on board), it would be fair to say that his involvement thus far has been a waste of shareholder resources, assets, and equity.

I would love to hear how a non-disclosing promoter who was paid by SCRC to be involved with the same P&D that the homophobic criminal JOSEPH ZAMPETTI was also paid to orchestrate back in 2013 could have anything of value to bring to the table w/regards to SCRC's business operations...


It will be interesting to see in the 10K if selling expenses remain closer to 65% during Q4'14 or have decreased back down closer to the 45% levels. As I've stated and shown the math for previously, "if" SCRC can bring Q4'14 selling expenses back down closer to the 45% that it had been AND the Q1'15 10Q reflects that this lowered selling expense rate has been maintained for Q1'15, then FROM A NET EARNINGS PERSPECTIVE this by itself will MORE THAN MAKE UP FOR the loss of CVS/Caremark revenues.

In the face of shrinking revenues and no signs of any new MATERIAL revenues coming online anytime soon, seeing Selling Expenses decrease back down closer to 45% is the one last meaningful REAL catalyst that we have that can not only turn the sp around in a hurry but enable it to be maintained at levels higher than where it currently sits... ...otherwise, there will certainly be many more fake catalysts and real-but-immaterial catalysts that will be hyped to high heaven by you-know-who, but these will all end up retracing back down just like every single other past catalyst (whether real or fake) has.

That's just the way pennyland works folks. Only REAL and MATERIAL news can move the sp in a way that can overcome the toxic effects of dilution. Without such news, dilution ALWAYS brings the sp back down -- at least until all the dilutive shares flush thru, and we are nowhere close to that here with SCRC...